Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome

Clinical trial NCT01673308 · UNKNOWN

Trial details

NCT number: NCT01673308
Sponsor: Ulsan University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2012-08-01
Primary completion: 2015-11-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.